IT+BT
Integrating high-throughput sequencing and artificial intelligence, we utilize core algorithms to predict and screen neoantigens
Neoantigen Screening System Powered by Core Patented Technologies
Via our core IP based screening system, to identify neoantigens that are presented by MHC class I/II molecules and capable of inducing specific TCR clonal expansion
Multi-omics + AI Companion Diagnostic Platform
Identifying specific companion diagnostic biomarkers by integrating multi-omics technologies and artificial intelligence
